SCHEMBL6115248

SCHEMBL6115248

CCCCCCCCCCCCc1cccnc1

nearest known ligand 0.96

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.96
L3MBTL1 Q9Y468 1/20 0.96
HRH1 P35367 2/20 0.68
CYP2A6 P11509 1/20 0.61
TBXAS1 P24557 7/20 0.60
TRPV1 Q8NER1 4/20 0.57
CHRNA7 P36544 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9549408 1.00 TDP1 (0.96) TDP1L3MBTL1HRH1CYP2A6TBXAS1
SCHEMBL6115279 1.00 TDP1 (0.96) TDP1L3MBTL1HRH1CYP2A6TBXAS1
SCHEMBL6114977 1.00 TDP1 (0.96) TDP1L3MBTL1HRH1CYP2A6TBXAS1
SCHEMBL6114843 1.00 TDP1 (0.96) TDP1L3MBTL1HRH1CYP2A6TBXAS1
SCHEMBL25381701 1.00 TDP1 (0.96) TDP1L3MBTL1HRH1CYP2A6TBXAS1
SCHEMBL919570 1.00 TDP1 (0.96) TDP1L3MBTL1HRH1CYP2A6TBXAS1
SCHEMBL25381172 1.00 TDP1 (0.96) TDP1L3MBTL1HRH1CYP2A6TBXAS1
SCHEMBL25380936 1.00 TDP1 (0.96) TDP1L3MBTL1HRH1CYP2A6TBXAS1
SCHEMBL25382598 1.00 TDP1 (0.96) TDP1L3MBTL1HRH1CYP2A6TBXAS1
SCHEMBL4461304 1.00 TDP1 (0.96) TDP1L3MBTL1HRH1CYP2A6TBXAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102050806-A Method for preparing product containing 5-hydroxymethyl furfural from lignocellulose XUE LI 2011-05-11 CN claimed
US-4562253-A Deacylation of amides BIOCHEMIE GESELLSCHAFT M.B.H. (AT) 1985-12-31 US claimed
CN-116323712-B Alkali releasing composition and curable resin composition using same 纳美仕有限公司 2024-09-03 CN disclosed
US-20230399550-A1 BASE-RELEASING COMPOSITION AND CURABLE RESIN COMPOSITION USING THE SAME NAMICS CORPORATION (JP) 2023-12-14 US disclosed
EP-4239025-A1 BASE-RELEASING COMPOSITION AND CURABLE RESIN COMPOSITION USING SAME Namics Corporation (JP) 2023-09-06 EP disclosed
CN-116323712-A Alkali releasing composition and curable resin composition using same 纳美仕有限公司 2023-06-23 CN disclosed
WO-2022091989-A1 BASE-RELEASING COMPOSITION AND CURABLE RESIN COMPOSITION USING SAME ナミックス株式会社 2022-05-05 WO disclosed
CN-112382746-B Preparation method of lithium ion battery anode material with heat closing and self-healing functions 湖南省正源储能材料与器件研究所 2021-04-23 CN disclosed
EP-2474527-B1 IONIC LIQUID CONTAINING ALLYLSULFONATE ANION WAKO PURE CHEM IND LTD (JP) 2017-01-25 EP disclosed
CN-104211620-B The autofrettage of bi-quaternary ammonium salt and its intermediate Wako-chem Industries Co., Ltd. (JP) 2016-05-25 CN disclosed
WO-2016042280-A1 CONJUGATES OF AMINO ACID-PYRIDINE/PYRIDINIUM AND USES THEREOF AS BIOCIDAL AGENTS Université de Nice Sophia Antipolis (FR) 2016-03-24 WO disclosed
CN-102482208-A Ionic Liquid Containing Allyl Sulfonate Anion WAKO PURE CHEM IND LTD 2012-05-30 CN disclosed
CN-102482197-A Process for producing diquaternary ammonium salt and novel intermediate WAKO PURE CHEM IND LTD 2012-05-30 CN disclosed
US-20120130107-A1 PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2012-05-24 US disclosed
CN-102050806-A Method for preparing product containing 5-hydroxymethyl furfural from lignocellulose XUE LI 2011-05-11 CN disclosed
CN-101279240-B Preparation of organic modified nano silicon oxide adsorbing material UNIV ZHEJIANG 2010-06-09 CN disclosed
CN-101279240-A Preparation of organic modified nano silicon oxide adsorbing material UNIV ZHEJIANG (CN) 2008-10-08 CN disclosed
EP-0108034-B1 DEACYLATION OF AMIDES BIOCHEMIE Gesellschaft m.b.H. (AT) 1987-01-28 EP disclosed
US-4562253-A Deacylation of amides BIOCHEMIE GESELLSCHAFT M.B.H. (AT) 1985-12-31 US disclosed
EP-0108034-A2 Deacylation of amides BIOCHEMIE Gesellschaft m.b.H. (AT) 1984-05-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120130107-A1 PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE ASS1, C1S, FHIT TDP1 3074/4885L3MBTL1 2236/4885HRH1 1114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.